Relmada Therapeutics (RLMD) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Relmada Therapeutics (RLMD) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - | 99.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.87% |
| Dec 31, 2025 | -18.59% |
| Mar 31, 2025 | -25,064.83% |
| Dec 31, 2024 | 43.67% |
| Sep 30, 2024 | 93.60% |
| Jun 30, 2024 | 91.68% |
| Mar 31, 2024 | 99.78% |
| Dec 31, 2023 | -1,206.31% |
| Dec 31, 2022 | -25,956.08% |
| Mar 31, 2021 | 55.11% |
| Sep 30, 2020 | -676.17% |
| Jun 30, 2020 | 664.95% |
| Mar 31, 2020 | -99.60% |
| Dec 31, 2019 | -226.28% |
| Sep 30, 2019 | 5.17% |
| Mar 31, 2019 | 85.24% |
| Dec 31, 2018 | 107.10% |
| Sep 30, 2018 | -220.77% |
| Mar 31, 2018 | 21.98% |
| Dec 31, 2017 | -344.04% |